Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00032279
Status:
UNKNOWN
Last Update Posted:
2005-06-24
First Post:
2002-03-15
Brief Title:
Research Study of Visilizumab for Treatment of Glucocorticoid- Refractory Graft Versus Host Disease
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Facet Biotech
Organization Data
Organization:
Facet Biotech
Class:
INDUSTRY
Study ID:
1589
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Fred Hutchinson Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Facet Biotech | INDUSTRY |